Nothing Special   »   [go: up one dir, main page]

Larrieu et al., 1972 - Google Patents

Comparative effects of fibrinogen degradation fragments D and E on coagulation

Larrieu et al., 1972

Document ID
4750055475420964153
Author
Larrieu M
Rigollot C
Marder V
Publication year
Publication venue
British Journal of Haematology

External Links

Snippet

The mechanism of anticoagulant action of the fibrinogen degradation products (fragments D and E) has been investigated using purified products in selected esterolytic, proteolytic and coagulation systems. Their modes of action were distinctly different. Fragment D acted …
Continue reading at onlinelibrary.wiley.com (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Micro-organisms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/814—Enzyme separation or purification

Similar Documents

Publication Publication Date Title
Larrieu et al. Comparative effects of fibrinogen degradation fragments D and E on coagulation
Goldsmith et al. The activation of plasminogen by Hageman factor (Factor XII) and Hageman factor fragments.
Colucci et al. Generation in plasma of a fast-acting inhibitor of plasminogen activator in response to endotoxin stimulation.
Hofsteenge et al. Enzymic properties of proteolytic derivatives of human. alpha.-thrombin
Mosnier et al. Plasma TAFI levels influence the clot lysis time in healthy individuals in the presence of an intact intrinsic pathway of coagulation
Stead et al. Inhibition of activated factor XII by antithrombin-heparin cofactor.
US4849403A (en) Protein C activator, methods of preparation and use thereof
Colburn et al. Anti-clotting activity of endothelial cell cultures and heparan sulfate proteoglycans
Pixley et al. Effect of heparin on the inactivation rate of human activated factor XII by antithrombin III
Walker Regulation of bovine activated protein C by protein S: the role of the cofactor protein in species specificity
Colman Effect of proteolytic enzymes on bovine factor VI Kinetics of activation and inactivation by bovine thrombin
Yin Effect of heparin on the neutralization of factor Xa and thrombin by the plasma alpha-2-globulin inhibitor
Kirchhof et al. The determination of prothrombin using synthetic chromogenic substrates; choice of a suitable activator
Tamada et al. Anticoagulant mechanism of sulfonated polyisoprenes
Chan et al. The inhibition of activated factor XII (Hageman factor) by antithrombin III: the effect of other plasma proteinase inhibitors
Rosenberg The effect of heparin on factor XIa and plasmin
Wang et al. Latent and active plasminogen activator in corneal ulceration.
Komori et al. Effect of bilineobin, a thrombin-like proteinase from the venom of common cantil (Agkistrodon bilineatus)
Salem et al. The light chain of factor Va contains the activity of factor Va that accelerates protein C activation by thrombin.
Lanchantin et al. Interaction of soybean trypsin inhibitor with thrombin and its effect on prothrombin activation
Kaplan et al. Molecular mechanisms of fibrinolysis in man
Pechet et al. The effect of certain proteolytic enzymes on the thrombin-fibrinogen interaction
Dyr et al. Conversion of fibrinogen to fibrin induced by preferential release of fibrinopeptide B
Blombäck et al. Action of a proteolytic enzyme inhibitor on blood coagulation in vitro
Costa et al. Partial characterization of an autoantibody recognizing the secondary binding site (s) of thrombin in a patient with recurrent spontaneous arterial thrombosis